Karthikeyan Subbarayan

Magdeburger Str. 2
Halle, NI 06112, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers.

Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers.

Journal: Journal of translational medicine

Published: January 02, 2025

Development of a StIW111C-based bioresponsive pore-forming conjugate for permeabilizing the endosomal membrane.

Development of a StIW111C-based bioresponsive pore-forming conjugate for permeabilizing the endosomal membrane.

Journal: International journal of biological macromolecules

Published: June 26, 2024

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors.

Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors.

Journal: Cellular and molecular life sciences : CMLS

Published: June 21, 2024

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.

Journal: Journal of translational medicine

Published: June 09, 2023

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.

Journal: Oncoimmunology

Published: December 19, 2022

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.

Journal: Oncoimmunology

Published: May 09, 2022

Identification of a novel miR-21-3p/TGF-β signaling-driven immune escape via the MHC class I/biglycan axis in tumor cells.

Identification of a novel miR-21-3p/TGF-β signaling-driven immune escape via the MHC class I/biglycan axis in tumor cells.

Journal: Clinical and translational medicine

Published: November 23, 2020

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.

Journal: Frontiers in immunology

Published: August 21, 2020

Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.

Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.

Journal: Current cancer drug targets

Published: July 15, 2020

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.

Journal: Journal of clinical medicine

Published: June 29, 2020

Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.

Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.

Journal: Cancer immunology, immunotherapy : CII

Published: February 07, 2019

Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.

Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.

Journal: Current cancer drug targets

Published: December 21, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026